Extension Study With Tosedostat in Relapsed/Refractory Acute Myeloid Leukemia

Clinical trial NCT01180426 · UNKNOWN

Trial details

NCT number: NCT01180426
Sponsor: Chroma Therapeutics
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2010-06-01
Primary completion: 2013-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.